Tocilizumab for severe COVID-19 pneumonia

Authors: Lipworth, Brian J. ;

Chan, Rory;

Kuo, Chris RuiWen

Source: The Lancet Rheumatology

Full text

: https://doi.org/10.1016/S2665-9913(20)30283-6

Abstract

Rights

Cite as

Lipworth, B., Chan, R. & Kuo, C. 2020, 'Tocilizumab for severe COVID-19 pneumonia', The Lancet Rheumatology, 2(11), pp. e660-e660. https://doi.org/10.1016/S2665-9913(20)30283-6

Downloadable citations

HTML BIB RIS

Identifiers

DOI: https://doi.org/10.1016/S2665-9913(20)30283-6

Repository URI: https://discovery.dundee.ac.uk/en/publications/dcaff3c4-083b-4348-8dfd-a02978457c3d